illness, unlike the stigma of other medical conditions (e.g., epilepsy, leprosy, and cancer), is still highly prevalent especially in middle-income countries. Negative stereotypes attached to mental illness are the main reason for discrimination. Therefore, the topic is important. The study is generally well-written and the results are interesting. However, I have some concerns. Title: Please remove study design from the title.
Introduction: It will be good to write about the burden of depression in the china. Stigma is very sensitive to culture. It should be also discussed in the introduction to convince the readers for doing such a study. Method It is not really clear about the study sampling. How the author concluded the sample are representative of the community? Beck Depression Inventory or the Center for Epidemiological Studies Depression scale are more reliable tools for screening for depression. Moreover, Gender bias in screening tools may lead to overdiagnosis of depression in women. The limitations of self-reported depression screening tools should be taken into the account. How depressed patients were diagnosed? Why did not use the CIDI 2.1? I am not happy with the translation procedure. The authors should use international guidelines. Have the authors done cognitive interviews with the patients? The response rate for the study should be reported. Analysis: I would recommend the authors to use factorial invariance across gender. I also suggest the authors to do discriminant validity using known group comparison between patients with different cancer stages.
VERSION 1 -AUTHOR RESPONSE
Reviewer(s)' Comments to Author: Reviewer: 1 1. In the introduction, a more comprehensive review of all studies that evaluated DSS psychometric properties is needed. Response: Following the Reviewer's suggestion, we have now added more information in the revised introduction. Specifically we now describe: The Depression Stigma Scale (DSS) has been validated and widely used to measure depression-related stigma in people with depression and general populations across different countries including Netherlands, Germany, Japan, and Australia. For example, Dietrich et al., (2014) translated the DSS into German and found that the German version of the DSS was suitable to measure depression stigma in general people and depressed patients (reference 15 in the manuscript). Boerema et al., (2016) translated the DSS into Dutch and established the validity and internal consistency of the DSS personal scale in a depressed sample and a community sample (reference 14 in the manuscript). Addressed in the paper: Please see Page 4-5.
2. Item responses were categorical (ordinal Likert data). So why the weighted least squares with adjustments for means and variances estimation (WLSMV), using polychoric correlation coefficients, was not used? Response: Following the Reviewer's suggestion, we have now calculated the polychoric correlation matrices and repeated the EFA based on the matrices. The analyses procedure was carried out by POLYMAT-C, an SPSS macro developed by Urbano et al., (2015) . The polychoric correlations are shown in Table 1 (personal stigma scale) and Table 2 (perceived stigma scale). The EFA based on the matrices also supported a two-factor structure for both personal and perceived depression stigma subscale. As shown in Table 3 , the factor structure of personal and perceived depression stigma were in line with our findings using the original analyses method of EFA.
Considering that all previous work validating depression stigma scale carried common exploratory factor analyses as what we did in the manuscript (see references 14-16 in the manuscript), a switch of analyses method may be difficult to compare our findings with previous research. We therefore decided to remain the original method of EFA in our manuscript. Addressed in the paper: .169 Note. The items with yellow background were excluded based on the EFA. This is in line with our original EFA analyses in the manuscript.
Reviewer: 2 This is a good article assessing factor structure and validation of the DSS in cancer patients. Although simplistic, appropriate analyses were conducted and presented clearly. However, since the CFA results are inconclusive, it is important to discuss the implications of the varying factor structure among the study population and for future research. Response: Our identified factor structure was partly in line, and partly different than previous factor structures identified in the general population and people with depression. Given these inconsistent findings regarding the factor structure in different types of samples, more research is needed to test the factor structure of DSS across different culture and different populations including cancer patients, healthy individuals and depressed persons. Following the Reviewer's suggestion, the above issue has been added in the revised manuscript. Addressed in the paper: Please see Page 13-14
Reviewer: 3 This study reports a Chinese validation of the Depression Stigma scale (DSS) among depressed cancer patients. Perceived stigma has been found to be different across patients with different mental disorders. The stigma of mental illness, unlike the stigma of other medical conditions (e.g., epilepsy, leprosy, and cancer), is still highly prevalent especially in middle-income countries. Negative stereotypes attached to mental illness are the main reason for discrimination. Therefore, the topic is important. The study is generally well-written and the results are interesting. However, I have some concerns. 1. Title: Please remove study design from the title. Response: we would like to thank the Reviewer for the positive feedback on our manuscript. As the Editor indicated above, the BMJ open requires each paper to indicate the study design in the title. We therefore kept the study design in the title. Addressed in the paper: 2. Introduction: It will be good to write about the burden of depression in the china. Stigma is very sensitive to culture. It should be also discussed in the introduction to convince the readers for doing such a study. Response: Following the Reviewer's suggestion, we have now added the information below about the burden of depression for Chinese cancer patients and the sensitive nature of stigma in the revised introduction: "Currently in China, depression has become one of the most common psychological problems for Chinese cancer patients, with more than half of Chinese cancer patients reported elevated levels of depression. A more severe depression may cause a lower quality of life, difficulties to insist on cancer treatment, long-term hospitalization, and elevated mortality. Therefore, it is important for cancer patients with elevated depression to seek professional psychological help. Yet, only a small number of them were indeed willing to seek help. Previous research has found that depression related stigma is a common issue that may cause a delay for help-seeking. But little is known regarding how cancer patients' depression stigma may influence their help-seeking". "No research has been conducted to examine whether DSS is suitable for cancer patients. Moreover, previous research was conducted in Western culture. Considering the culturally sensitive experiences of depression stigma, psychometric properties of the DSS cannot be assumed when used in a culture vastly different from its Western origin. We therefore tested psychometric properties of the DSS in a sample of Chinese people." Addressed in the paper: Please see Page 4-5.
3. Method: It is not really clear about the study sampling. How the author concluded the sample are representative of the community? Response: in this study, we focused on a sample including people with heterogeneous types of cancer. Particularly, breast cancer, lung cancer, gastric cancer, and gynecological cancer were the most common cancer types in our study, which is in line with the cancer statistics in China (see reference 24 in the manuscript). Therefore, based on this comparison, our sample seems representative of the community of cancer patients in China. Following the Reviewer's suggestion, the above information about the study sampling has been added in the revised manuscript. Addressed in the paper: please see Page 5.
Beck Depression Inventory or the Center for Epidemiological Studies
Depression scale are more reliable tools for screening for depression. Moreover, gender bias in screening tools may lead to overdiagnosis of depression in women. The limitations of self-reported depression screening tools should be taken into the account. How depressed patients were diagnosed? Why did not use the CIDI 2.1? Response: Previous research has shown that the PHQ-9 is a valid and commonly used instrument to assess the severity of depressive symptoms in general population and cancer patients (see references 19 and 20 in the manuscript). Compared with the length of CES-D and BDI, the PHQ-9 was relatively shorter. We therefore selected the PHQ-9, as we wanted to limit the burden for patients to take part in this research. The Reviewer is indeed correct that the use of self-report questionnaires for depressive symptoms is likely to lead to an overestimation of depressive symptoms. Future study should use a clinical diagnostic instrument (e.g., CIDI 2.1) to measure depressive symptoms and examine the relationships between depression stigma and depressive symptoms. Following the Reviewer's suggestion, this issue is now explicitly described as one of our limitation in the paper. Addressed in the paper: please see page 16.
5. I am not happy with the translation procedure. The authors should use international guidelines. Have the authors done cognitive interviews with the patients? Response: in the current study, the DSS was translated into Chinese according to a multiple forward and backward procedure, which has been widely used for Depression Stigma Scale translation and validation in previous research (see references 14-16 in the manuscript). In our study, two independent researchers translated the questions from English to Chinese. Differences in translation were discussed between researchers and a single version was agreed upon. This version was then translated back into English by a third researcher. That version was then compared to the original version of the DSS. Again, potential differences were discussed by two authors. Given that the DSS has been validated and widely used across different countries, we did not conduct cognitive interview about participants' thoughts on depression stigma.
In the revised mansucript, we have now provided a clearer description about the translation procedure of the DSS. Addressed in the paper: please see page 7.
6. The response rate for the study should be reported. Response: following the Reviewer's suggestion, we have added the response rate in the revised manuscript. Addressed in the paper: please see page 9.
7. Analysis: I would recommend the authors to use factorial invariance across gender. I also suggest the authors to do discriminant validity using known group comparison between patients with different cancer stages. Response: Following the Reviewer's suggestion, we have tested factorial invariance between genders of the personal and perceived depression stigma subscales respectively (see table 4 ). Based on the analyses below, it can be concluded that there were no factorial variances between male and female. As it was not the aim of the paper to examine possible factorial invariance across subgroups, we would like to suggest to not include the results of these extra analyses in the paper. Of course, if the reviewer or editor thinks this makes the paper better, we are very willing to add them.
For the personal depression stigma subscale, the configural model showed an acceptable model fit with S-Bχ 2 = 13.708, df = 8, CFI = .972, TLI = .931, RMSEA = .072. This finding suggested that there were same factor-structure across genders. Then we compared the metric invariance model with configural model with △S-Bχ 2 = 2.761, △df = 3, p > .05, indicating that there were the same scaling unit for both genders. Next, a comparison between the metric invariance model and the scalar invariance model showed that △S-Bχ 2 = 2.020, △df = 3, p > .05, indicating a same scaling origin for both genders. Hence, compared with the scalar invariance model, the invariance of error variance model showed △S-Bχ 2 = 3.719, △df = 5, p > .05, and the invariance of factor variance-covariance model showed △S-Bχ 2 = 1.490, △df = 3, p > .05, meaning that both genders have same error variance and same factor variance, covariance. At last, we compared the invariance of latent mean model and the invariance of factor variancecovariance model, and it showed △S-Bχ 2 = .277, △df = 2, p > .05, indicating that two genders have same latent mean.
For the perceived depression stigma subscale, the configural model showed acceptable model fit with S-Bχ 2 = 8, df = 8, CFI = 1, TLI = 1, RMSEA = .001, which suggested that a same factor structure across genders. A comparison between the metric invariance model and configural model showed △S-Bχ 2 = 3.258, △df = 3, p > .05, indicating a same scaling unit for both genders. Then we compared the metric invariance model with the scalar invariance model, showing that △S-Bχ 2 = .965, △df = 3, p > .05, and it meant that the same scaling origin for both genders was supported. Next, compared with the scalar invariance model, the invariance of error variance model showed △S-Bχ 2 = 6.109, △df = 5, p > .05, and the invariance of factor variancecovariance model showed △S-Bχ 2 = 2.543, △df = 3, p > .05, meaning that both genders have same error variance and same factor variance, covariance. At last, we compared the invariance of latent mean model and the invariance of factor variance-covariance model, and it showed △S-Bχ 2 = 1.114, △df = 2, p > .05, indicating that two genders have same latent mean. Addressed in the paper: 
